These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29966502)

  • 1. A Bayesian model to estimate the cutoff and the clinical utility of a biomarker assay.
    Vradi E; Jaki T; Vonk R; Brannath W
    Stat Methods Med Res; 2019 Aug; 28(8):2538-2556. PubMed ID: 29966502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating measures of diagnostic accuracy when some covariate information is missing.
    Paliwal P; Gelfand AE
    Stat Med; 2006 Sep; 25(17):2981-93. PubMed ID: 16345056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating uncertainty into medical decision making: an approach to unexpected test results.
    Bianchi MT; Alexander BM; Cash SS
    Med Decis Making; 2009; 29(1):116-24. PubMed ID: 18812583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a diagnostic test based on multiple continuous biomarkers with an imperfect reference test.
    García Barrado L; Coart E; Burzykowski T;
    Stat Med; 2016 Feb; 35(4):595-608. PubMed ID: 26388206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables.
    Jiang Z; Song Y; Shou Q; Xia J; Wang W
    Trials; 2014 Dec; 15():500. PubMed ID: 25528466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Bayesian approach to model the conditional correlation between several diagnostic tests and various replicated subjects measurements.
    Pereira da Silva HD; Ascaso C; Gonçalves AQ; Orlandi PP; Abellana R
    Stat Med; 2017 Sep; 36(20):3154-3170. PubMed ID: 28543307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayes' theorem: a paradigm research tool in biomedical sciences.
    Okeh UM; Ugwu AC
    East Afr J Public Health; 2009 Apr; 6 Suppl(1):11-9. PubMed ID: 20088070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian modeling and inference for diagnostic accuracy and probability of disease based on multiple diagnostic biomarkers with and without a perfect reference standard.
    Jafarzadeh SR; Johnson WO; Gardner IA
    Stat Med; 2016 Mar; 35(6):859-76. PubMed ID: 26415924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian estimation of intervention effect with pre- and post-misclassified binomial data.
    Stamey JD; Seaman JW; Young DM
    J Biopharm Stat; 2007; 17(1):93-108. PubMed ID: 17219757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian approach to toxicological testing.
    Felli JC; Leishman DJ
    J Pharmacol Toxicol Methods; 2020 Sep; 105():106898. PubMed ID: 32735877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian approaches to benefit-risk assessment for diagnostic tests.
    Bai T; Lan H; Tiwari R
    J Biopharm Stat; 2021 Jul; 31(4):541-558. PubMed ID: 34092194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferring cut-off values between assays for cerebrospinal fluid Alzheimer's disease biomarkers.
    García Barrado L; Coart E; Vanderstichele HMJ; Burzykowski T
    J Alzheimers Dis; 2016; 49(1):187-199. PubMed ID: 26484919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Bayes theorem to estimate positive and negative predictive values for continuously and ordinally scaled diagnostic tests.
    Fischer F
    Int J Methods Psychiatr Res; 2021 Jun; 30(2):e1868. PubMed ID: 33650777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approximate confidence intervals for the likelihood ratios of a binary diagnostic test in the presence of partial disease verification.
    Montero-Alonso MA; Roldán-Nofuentes JA
    J Biopharm Stat; 2019; 29(1):56-81. PubMed ID: 29584541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions.
    Subtil F; Rabilloud M
    BMC Med Inform Decis Mak; 2014 Jun; 14():53. PubMed ID: 24927622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Bayesian and frequentist methods for prevalence estimation under misclassification.
    Flor M; Weiß M; Selhorst T; Müller-Graf C; Greiner M
    BMC Public Health; 2020 Jul; 20(1):1135. PubMed ID: 32689959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using population-based serum drug concentration cutoff values to predict toxicity: test performance and limitations compared with Bayesian interpretation.
    Schumacher GE; Barr JT
    Clin Pharm; 1990 Oct; 9(10):788-96. PubMed ID: 2242660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different evidence summaries have implications for contextualizing findings of meta-analysis of diagnostic tests.
    Zgodic A; Schmid CH; Olkin I; Trikalinos TA
    J Clin Epidemiol; 2019 May; 109():51-61. PubMed ID: 30654146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian bootstrap estimation of ROC curve.
    Gu J; Ghosal S; Roy A
    Stat Med; 2008 Nov; 27(26):5407-20. PubMed ID: 18613217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint confidence region estimation on predictive values.
    Schaible BJ; Yin J
    Pharm Stat; 2021 Nov; 20(6):1147-1167. PubMed ID: 34021708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.